Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874716-25-000002
Filing Date
2025-01-21
Accepted
2025-01-21 17:00:34
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 wk-form5_1737496826.html 5  
1 FORM 5 wk-form5_1737496826.xml 5 3038
  Complete submission text file 0000874716-25-000002.txt   4534
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Issuer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092
Business Address
Erickson Michael G (Reporting) CIK: 0002005385 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-19271 | Film No.: 25543182